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Abstract: Human Papillornavirus (HPV) infection has been shown as a risk factor in oral 
carcinogenesis. The association between HPV and benign and malignant neoplasm of oral 
mucosa, especially surface epithelium-derived tumors, is well established. The role ofHPV 
in pathogenesis of odontogenic cysts and tumors has been published in few articles. The aim 
of this study was detection of HPV in Iranian patients with intrabony arneloblastoma and 
investigation of specific risk factors associated with arneloblastoma. One hlllldred intrabony 
arneloblastoma and 50 age-sex matched samples as controls were evaluated by polymerase 
chain reaction for the detection and typing ofHPV. Fisher exact and chi square tests were 
used to assess the data. HPV DNA was detected in 32% of patients and 10% of controls. 
HPV-6 was the most prevalent genotype (31.6%) in infected cases. It was followed by 
HPV-11 (12.5%), HPV-16 (12.5%) and HPV-31 (3.1 %). We found a significant association 
between presence ofHPV and location of tumor (p = 0.02), traumatic history (p = 0.03) and 
ododontic therapy (p = 0.01). These findings indicated that HPV-6 probably is one of the 
most important etiologic agents in causing intraosseous arneloblastoma in Iranian population. 
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Introduction 
Arneloblastoma has been associated with the most complex group of pathogenic viruses. 
Eighty-five genotypes of HPV have been fully characterized (zur Hausen, 1999). The association 
between Human Papillomavirus (HPV) and development ofbenign and malignant oral neoplasm is well 
established (Bouda et al., 2000; Sumrnersgill et al., 2000; Van Rensburg et al., 1996; Miller et al., 1996; 
Fomatora et al., 1996; Dekrnezian et al., 1987). The role of HPV in oral cancer is inevitable and 
presumably HPV is a cofactor in 100% of patients who developed oral cancer in 4-12 years of age 
(Nielson et al., 1996). The specific HPV types, most notably types 16, 18 and a few others, 
have been shown to cause the majority of cervical cancers and their high-grade precursor lesions 
(zur Hausen, 1999). Some types also seem to be responsible for other anogenital and a subset of head 
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and neck cancers (zur Hausen, 2002). Association between HPV and odontogenic cysts and tumors 
has been studied in a few cases (Sand et al., 2000). Particularly, types 6, 11, 16 and 18 have been 
detected in peripheral and intrabony ameloblastoma (Sand et al., 2000; Kahn, 1991, 1989). The aim 
of the current study was to investigate the presence of HPV in intrabony arneloblastorna by PCR, 
using consensus primers and identify different genotypes, using type-specific primers. 
Materials and Methods 
Through 1999-2000 one hlllldred blocks ofparaffin embedded tissue intraosseous arneloblastorna 
were retrieved from the archives of the Department ofOral Pathology, Dental School, Shahid Behesht:i 
University of Medical Sciences and the Department of Pathology, Taleghani General Hospital, Tehran. 
The tissues with arneloblastorna were providing confirmed by pathologists. The control samples 
selected from dental follicles of patients, referred to our clinics for excision were of their 
impacted teeth. They were selected if their histopathologic examinations showed no evidence 
of arneloblastic changes. 
All of the cases and controls were classified in four groups of age. With respect to the tumor site, 
90 were located in mandible and 10 in maxilla. Thirty-five patients were smoker. We also recorded 
history of tooth extraction, endodontic surgery and tooth repair in cases and control groups. 
Four to six 5 µm sections were cut from each paraffin embedded tissue and placed in 2.5 rnL 
Eppendorf tubes. DNA was extracted as described previously (Fomatora et al., 1996). In brief, the 
sections were deparaffinized in 2 mL Xylene, this was repeated for three times. Xylene was pipetted 
off and its residue was removed using 2 mL of 100% ethanol. It was followed by vortexing and 
spinning. Most of the ethanol was pipetted off and the remaining was removed by incubation at 56°C 
for 30 min. Two hundrad microliter digestion buffer (50 mM KCL, 1.5 mM MgCl,, 10 mM HCL, 
0.45% v/v Tween 20, 10 mg mL- 1 proteinase K (pH= 8.3) was added and incubated overnight at 
36°C. Proteinase K was inactivated by incubation at 95°C for 8 to 10 min. This was followed by 
spinning at 7000 rpm for 5 min. The supernatant was collected in a clean and sterile tube and stored 
at -20°C for PCR processing. 
HPV DNA was amplified with GP''/GP'' primers (Jacobs et al., 1995), which amplify a 
portion of the Ll gene of most ofmucosal HPV types (Table 1). Preparations were also tested by 
Table 1: Polymerase chain reaction primers 
Type of primers Primers sequences Length ofPCR products (bp) 
p-globin• PC03 Y ACACAACTGTGTTCACTAGC 110 
PC04 5, CAA CTT CAT CCA CGT TCA CC 
GP5+ Y TIT GIT ACT GTG GTA GAT ACT AC 150 
GP6+ YGAA AAA TAA ACT GTA AAT CAT ATI C 
HPV6.1' +Y TAGTGGGCCTATGGCTCGTC 3' 280 
HPV6.2 -5' TCCATIAGCCTCCACGGGTG 3' 
HPV 11.1' +Y GGA ATA CAT GCG CCA TGT GG 3' 360 
HPV 11.2 -5' CGA GCA GAC GTC CGT ccr CG 3' 
HPV 16.1' +Y TGCTAGTGCTTATGCAGCAA 3' 152 
HPV 16.2 -5' ATITACTGCAACATIGGTAC 3' 
HPV 18.1' +Y AAGGATGCTGCACCGGCTGA 3' 216 
HPV 18.2 -5' CAC GCA CAC GCT TGG CAG GT 3' 
HPV31.1' +5' ATGGTGATGTACACAACACC 3' 514 
HPV 31.2 -5' GTA GTT GCA GGA CAA CTG AC 3' 
HPV33.1' +Y ATGATAGATGATGTAACGCC 3' 455 
HPV33.2 -5' GCA CAC TCC ATG CGT ATC AG 3' 
a-(Baay et al., 1996); b-(Jacobs et al., 1995); c-(Melchers et al., 1994) 
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PCR with primers PC03 and PC04 (Baay et al., 1996), specific to the human p-globin gene to monitor 
the integrity of DNA in the samples and the potential of amplification. Only samples showing 
successful amplification of p-globins sequences were subjected to GP 5+/GP 6 + PCR. All HPV 
positive specimens were further analyzed with type-specific primers for HPV types 6, 11, 16, 18, 31 
and 33 (Melchers etol., 1994) (Table 1). 
Ten rnicroliters of the DNA solution were used for PCR in 50 µL of reaction mixture, containing 
10 mM Tris-HCl (pH~ 8.3), 50 mM KC!, 2.5 mM MgCl,, 0.01 % gelatin, 10 mM each dNTP (dATP, 
dTTP, dCTP, dGTP), 1 unit Taq polymerase and 50 pmol of each primers GP''/GP''. Each cycle 
included 1 min denaturat:ion at 94°C, annealing step at 40°C for 2 min and extension at 72°C 
for 1.5 min. Forty cycles of PCR amplification were performed. The first cycle was preceded by a 
5 min denaturation at 95°C and the last cycle was extended by a 4 min elongation at 72°C. Descriptive 
statistic was performed and were analyzed by chi-square for categorical variables. 
Results 
Human Papillomavirus (HPV) DNA was detected in 32 (32%) patients and 5 (10%) of the 
controls. HPV genotyping using type-specific-primers, detected HPV-6, 11, 16 and 31 in 10 (31.6%), 
4 (12.5%), 4 (12.5%), 1 (3.1%) positive of samples, respectively. Mix infection of types 6 and 16 was 
revealed in 2 (6.3%) positive samples. HPV 18 and 33 were not detected. Eleven (34.4%) HPV 
positive specimens were not identified by the specific primers used in this study (Table 2). 
HPV-6 was the predominant type, being present in 31.6% of the infected cases, either alone or 
together with other types. A significant association was observed between the location of tumor and 
the presence ofHPV (p = 0.02). There was a strong correlation between traumatic history and HPV 
infection (p = 0.03). In addition, HPV infection showed a significant correlation with age group of 
36-45 years (p = 0.03). We folllld also a significant correlation between endodontic therapy and HPV 
presence (p = 0.01). In relation to further clinicopathologic features of the analyzed patients, statistical 
analysis revealed no correlation between HPV infection and gender, tooth extraction, smoking, type 
of tumor and history of operative dentistry procedure (Table 3). 
Table 2: Frequency of cases and controls and the results ofHPV types detection 
Cases Controls 
Characteristic n % HPV % n % HPV % 
Age/years 
16-25 34 34 13 38.3 18 36 2 11.8 
26-35 35 35 6 17.2 17 34 1 5.9 
36-45 21 21 11 52.4 11 22 1 9.1 
46-55 10 10 2 20.0 4 8 25.0 
Table 3: Clinicopathological feahJre of samples and the results ofHPV detection 
Extraction 
Samples Ag~ear y,~ No Endo R~air Trauma Smoking HPV+ 
Cases 16-25 25 9 10 24 7 4 13 
26-35 28 7 16 27 5 17 6 
36-45 19 2 8 20 10 11 11 
46-55 10 4 7 2 3 2 
Controls 	 16-25 15 3 9 15 5 3 2 
26-35 12 5 5 12 3 9 1 
36-45 9 2 4 10 4 4 1 
46-55 3 1 1 2 1 1 1 
Total 121 29 57 117 37 52 37 
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Discussion 
The role of human papillornavirus infection in the development of benign, prernalignant 
and malignant lesions of oral mucosa has received attention in the past several years 
(Van Rensburg et al., 1996; Miller et al., 1996; Fornatora et al., 1996; Dekrnezian et al., 1987; 
Eversole et al., 1987). These lesions are surface epithelium-derived. Arneloblastorna is an 
epitheliurn-derivedlesion with odontogenic origin (Harada et al., 1998). Some studies suggest 
an association between HPV and arneloblastorna (Sand eta/., 2000; Kahn, 1991; Kahn, 1989; 
Harada et al., 1998; Van-Heerden et al., 1993). The HPV has been proposed to be one of the initiating 
factors by authors. Unspecified disturbances, including pressure and nutritional disturbances, rickets, 
extraction, caries and tooth repair, endodontic surgery, several oral sepsis, viruses might be of 
important in initiating ameloblastoma (Robinson, 1973; Tsahn and Nelson, 1980; Stanley et al., 1964; 
Ueno et al., 1986; Mehlisch et al., 1972; Goldberg and Friedman, 1975; Forsberg, 1954; Csiba et al., 
1970; Levy and Ring, 1950; Main and Dawe, 1966; Fleining, 1963). In the present study, 32% of 
ameloblastoma specimens were HPV positive. Kahn found HPV in three (two intrabony and one 
peripheral) of thirty-eight juvenile ameloblastoma (Kahn, 1989). He concluded that the HPV presence 
in peripheral ameloblastoma is expected and proposed that the virus is acquired in uteri or at 
purhui.tition and involves the invaginating primitive enamel organ. He described the HPV-6/18 
in a peripheral ameloblastoma (Kahn, 1991). In other study, Sand and his co-workers investigated 
12 intrabony ameloblastoma by southern blot hybridization; five cases (42%) were HPV positive 
(Sand et al., 2000). In study cani.ed out in Texas, America on 5 patients types 11 and 16 were spotted 
(Dekrnezian et al., 1987). Interestingly in another report articulated by other workers concerning 
62 samples, types 2, 6, 11 were detected (Eversole et al., 1987). Another worker detected 
HPV type 18 in ameloblastoma (Van-Heerden et al., 1993). Present findings showed a high prevalence 
of HPV-6 and 11 (31.6 and 12.5%, respectively). These types of HPV were found in one peripheral 
ameloblastoma in Kahn's study (Kahn, 1991) and in 4 of 8 (50%) HPV positives studied by 
Sand et al. (2000) HPV-16 was detected in 4 (12.5%) cases in the present study. Kahn (1991) also 
found this type in one peripheral ameloblastoma it was not detected. We also found HPV-31 in one 
(3.1 %) of HPV positive cases, it was not reported in other studies. HPV-18 that was detected 
(Kahn, 1991) and in 7 of 8 (87%) HPVpositive cases in was not found in our investigation 
(Sand et al., 2000). From the clinical point ofview, 56 (56%) of our cases were males and forty-four 
( 44%) were females. Kahn (1989) reported that 47.4% were males and 52.6% were females, while 
in Sand investigation, 9 (75%) were males and 3 (25%) were females. However, it seems that there is 
no significant correlation between sex and HPV presence. A significant correlation between age and 
HPV infection was shown in the present study. All three cases were under 20 years old and in Sand 
study, almost all cases were between 44 to 53 years old. These correlation derived from different 
studies are not consistent and therefore, further investigation is needed to clarify possible correlation 
between age and HPV. In present investigation for the first time, an analytical study showed a 
significant correlation between intrabony ameloblastoma and HPV presence. These findings emphasis 
the role of HPV as an important etiologic factor of ameloblastoma. However, as Kahn (1989) proposed 
the penetration of HPV via the primitive oral mucosa to enamel organ and then dental follicle it is 
possible that HPV can penetrate from the oral squamous epithelium when a trauma, tooth extraction, 
endodontic surgery or similar stimulation occurs. Further studies need to test this hypothesis. 
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